Academic literature on the topic 'Antiretroviral Treatment'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Antiretroviral Treatment.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Antiretroviral Treatment"
Boelaert, Johan R., and Kirk Sperber. "Antiretroviral treatment." Lancet 352, no. 9135 (October 1998): 1224–25. http://dx.doi.org/10.1016/s0140-6736(05)60566-1.
Full textLange, Joep M. A., David A. Cooper, and Sven A. Danner. "Antiretroviral treatment." AIDS 5, Supplement (January 1991): 181–88. http://dx.doi.org/10.1097/00002030-199101001-00026.
Full textMaeland, Arild. "Antiretroviral treatment initiation." Lancet Infectious Diseases 14, no. 12 (December 2014): 1175. http://dx.doi.org/10.1016/s1473-3099(14)70947-8.
Full textGupta, Samir K. "Antiretroviral treatment initiation." Lancet Infectious Diseases 14, no. 12 (December 2014): 1175–76. http://dx.doi.org/10.1016/s1473-3099(14)70951-x.
Full textHarris, Marianne. "Raltegravir: Its use in the Treatment of HIV Infection." Clinical Medicine. Therapeutics 1 (January 2009): CMT.S32. http://dx.doi.org/10.4137/cmt.s32.
Full textMontaner, Julio SG, Robert Hogg, Janet Raboud, Richard Harrigan, and Michael O'Shaughnessy. "Antiretroviral treatment in 1998." Lancet 352, no. 9144 (December 1998): 1919–22. http://dx.doi.org/10.1016/s0140-6736(98)07532-1.
Full textKeiser, Olivia, Angèle Gayet-Ageron, Christoph Rudin, Martin WG Brinkhof, Erika Gremlich, Dorothea Wunder, Gero Drack, Bernard Hirschel, and Begoña Martinez de Tejada. "Antiretroviral treatment during pregnancy." AIDS 22, no. 17 (November 2008): 2323–30. http://dx.doi.org/10.1097/qad.0b013e3283189bf1.
Full textArduino, R. "New antiretroviral treatment options." International Journal of Infectious Diseases 73 (August 2018): 37. http://dx.doi.org/10.1016/j.ijid.2018.04.3505.
Full textStek, Alice Marie. "Antiretroviral treatment in pregnancy." Current Opinion in HIV and AIDS 3, no. 2 (March 2008): 155–60. http://dx.doi.org/10.1097/coh.0b013e3282f50bfe.
Full textHammer, Scott M. "Antiretroviral Treatment as Prevention." New England Journal of Medicine 365, no. 6 (August 11, 2011): 561–62. http://dx.doi.org/10.1056/nejme1107487.
Full textDissertations / Theses on the topic "Antiretroviral Treatment"
Chivonivoni, Tamuka. "Antimycobacterial treatment among children at start of antiretroviral treatment and antimycobacterial treatment after starting antiretroviral treatment among those who started antiretroviral treatment without antimycobacterial treatment at a tertiary antiretroviral paediatric clinic in Johannesburg, South Africa." Thesis, University of the Western Cape, 2010. http://etd.uwc.ac.za/index.php?module=etd&action=viewtitle&id=gen8Srv25Nme4_3784_1360929496.
Full textBackground: Although clinicians encounter antimycobacterial treatment in Human mmunodeficiency (HIV)-infected children as one of the most common treatments coadministered with antiretroviral treatment (ART), quantitative data on the extent of antimycobacterial treatment among HIV-infected children at the time of commencement of ART and at different times during ART is scarce. The baseline risk factors associated with being on both ART and antimycobacterial treatments are not known and it remains to be elucidated how the different exposure factors impact on the antimycobacterial treatment-free survival of children who begin ART without antimycobacterial treatment.Objectives: To describe the prevalence of antimycobacterial treatment among children at the time of starting ART and the antimycobacterial treatment-free survival after starting ART. Design: A retrospective cohort study based on record reviews at the Harriet Shezi children&lsquo
s clinic (HSCC).Population: HIV-infected children less than fifteen years of age presumed ART naï
ve started on ART at HSCC.Analysis: A descriptive analysis of the prevalence of antimycobacterial treatment at time of start of ART was done. Kaplan Meier (KM) survival curves were used to determine the antimycobacterial treatment-free survival and logistic regression was used to analyze the association between baseline factors and future antimycobacterial treatment among children who had no antimycobacterial treatment at time of start of ART. Results: The prevalence of antimycobacterial treatment at the time of starting ART was 518/1941 (26.7%, 95% confidence interval (CI): 24.7-28.7). Among children who started ART without antimycobacterial treatment, the KM cumulative probability of antiretroviral and antimycobacterial (ART/antimycobacterial) co-treatment in the first 3 months of starting ART was 4.6% (95% CI: 4.1- 5.2), in the first 12 months it was 18.1% (95% CI: 17.0-19.2) and in the first 24 months of starting ART it was 24% (95% CI: 21.9-25.1). Survival analysis suggested that children with high baseline viral load, advanced World Health Organization (WHO) stage of disease, very low normalized weight for age (waz) and very young age (less than one year) at start of ART had significantly reduced antimycobacterial treatment-free survival (log rank p <
0.05) in the first two years of starting ART. In the logistic regression model, age less than one year {Odds ratio (OR): 3.7 (95% CI: 2.2-6.0
p <
0.0001)} and very low weight for age Z-score (waz <
-3) {OR
2.2 (95% CI: 1.4-3.6
p = 0.0015)} were the two critical risk factors independently associated with future antimycobacterial treatment. Conclusions: Antimycobacterial treatment is extremely common among HIV-infected children at the time of starting ART and early after starting ART and the incremental risk of being on ART/antimycobacterial co-treatment decreases with time on ART. The results emphasize the need for a heightened and careful alertness for mycobacterial events especially among children starting ART with severe malnutrition and those who start ART at age less than one year. The results further suggest that it is probably optimal to start ART in children before their nutritional status has deteriorated severely in the course of the HIV disease so that they get protection against mycobacterial events by early ART.
Södergård, Björn. "Adherence and Readiness to Antiretroviral Treatment." Doctoral thesis, Uppsala University, Department of Pharmacy, 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-7282.
Full textAntiretroviral therapy places extraordinarily high demands on adherence, since non-adherence affects both individuals and society due to the spread of resistant viral strains. The aims of the thesis were to investigate the prevalence of adherence in Swedish HIV-infected patients, changes in adherence over time, and factors associated with adherence, including patients’ readiness to adhere. Further, to investigate the collaboration between nurses, doctors and pharmacists after the introduction of a HIV-clinic satellite pharmacy. Data were collected via two cross-sectional patient surveys in 1998 and 2002, qualitative interviews with health care personnel at a major HIV clinic, and a nation-wide, cross-sectional patient survey in 2003-2004.
The level of adherence improved from 28% in 1998 to 57% in 2002, possibly due to simplified treatment and a new multi-professional treatment model at the clinic. The proportion of adherent patients was 63% in the nationwide survey. Factors associated with adherence were high age, high quality patient-provider relationships, no drug or alcohol problems and shorter time on treatment.
A hypothesized structural equational model, using readiness and adherence as separate latent concepts, was tested and found to support readiness as a distinct factor influencing adherence.
The health care personnel believed that conventional pharmacies had several disadvantages in serving the HIV infected population. They found the HIV-clinic satellite pharmacy valuable, since it contributed to increased communication and trust between the health care professions, and improved teamwork in medication management.
In conclusion, the level of adherence increased over time, and several factors associated with adherence were identified. Improved collaboration between health care professionals may enhance treatment support, and increased attention should be given to interventions that focus on the individual’s readiness for behavioural change in order to optimize treatment outcomes.
Södergård, Björn. "Adherence and readiness to antiretroviral treatment /." Uppsala : Acta Universitatis Upsaliensis, 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-7282.
Full textWasti, Sharada Prasad. "Adherence to antiretroviral treatment in Nepal." Thesis, University of Sheffield, 2012. http://etheses.whiterose.ac.uk/2750/.
Full textTerblanche, Lauren Muriel. "The knowledge about HIV/AIDS and antiretroviral treatment of patients receiving antiretroviral therapy." Thesis, Stellenbosch : Stellenbosch University, 2012. http://hdl.handle.net/10019.1/20131.
Full textENGLISH ABSTRACT: Many HIV positive patients are on antiretroviral therapy (ART) to assist in decreasing the replication of the HIV virus within the body. Adherence to this medication is important, as non- adherence can have serious repercussions. Therefore, the patients’ knowledge of ART and their disease is crucial in ensuring good adherence. A range of barriers to patient education were suspected by the researcher in this community of Delft. The high influx of patients into the clinic everyday minimized consultation time and thereby diminished the opportunity for effective patient education. Consequently, adherence to medication which is closely related to the knowledge and understanding of patients about the disease may be affected. The following research question was therefore explored: What is the knowledge of infected HIV/AIDS patients who are receiving antiretroviral treatment about HIV/AIDS and ART? The objectives set were to evaluate the patient’s knowledge of HIV/AIDS, evaluate the knowledge of ART and to determine whether there are statistical differences between the dependant and independent variables within the study. A quantitative descriptive correlational research design was applied and a convenience sample of n= 200 (8.5%) patients was selected from a population of N= 2349 at the Delft Community Health Centre. A multiple choice questionnaire comprising of mainly closed ended questions with multiple responses was used in individual interviews conducted by either the researcher or fieldworker. Reliability and validity was ensured through the consultation of experts in the fields of research methodology, statistics, HIV/AIDS and the Health Research Ethics Committee of Stellenbosch University. Permission to conduct this study was granted by the Health Research Ethics Committee of Stellenbosch University, the Provincial Regional Head for Primary Health Care Services, as well as the head of the Delft Community Health Centre. Data revealed that the participants were mainly female (n=145/72.5%), and the mean age was 37.5 years. Participants were mostly Xhosa speaking and literate, and the majority (n=112/56%), of the participants had a highest education level between grade 9 and grade 12. Many (n=73/36.5%) of the participants had been living with HIV for more than 5 years, but had been on ART for between 1 to 3 years. Knowledge was assessed by asking questions about various aspects of HIV and ART throughout the study. Scores for the 14 critical questions revealed that (n=0/0%) of the participants had good knowledge, (n=40/20%) of the participants had average knowledge and (n=160/80%) of the participants had poor knowledge. The average score for all participants for all 20 knowledge testing questions was (12.6/63%). The findings showed that the overall knowledge (n=160/80%) is poor. Basic terms and principles of HIV/AIDS and ART were not understood and serious misconceptions regarding the disease were revealed.
AFRIKAANSE OPSOMMING: Baie MIV positiewe pasiënte is op antiretrovirale terapie (ART) om te help met die vermindering van die replisering van die HIV virus in die liggaam. Gebruik van hierdie medikasie is belangrik omdat versuiming van inname ernstige gevolge kan hê. Dus, is die pasiënte se kennis van ART en hul siekte van deurslaggewende belang om volgehoue inname te verseker. ’n Reeks van hindernisse om pasiënte te onderrig, is deur die navorser in die Delftgemeenskap vermoed. Die hoë toestroming van pasiënte na die kliniek elke dag het die konsultasietyd tot die minimum beperk en daardeur die geleentheid vir effektiewe pasiëntonderrig laat verminder. Gevolglik, kan die nakoming om die medikasie te neem wat ’n noue verband toon met die kennis en begrip wat pasiënte het oor die siekte, geaffekteer word. Die volgende navorsingsvraag is gevolglik ondersoek: Wat is die kennis van geïnfekteerde HIV/VIGS pasiënte wat antiretrovirale behandeling ontvang oor HIV/VIGS en ART? Die doelwitte wat gestel is, is om die pasiënt se kennis van HIV/VIGS te evalueer, die kennis van ART te evalueer en te bepaal of daar ’n statistiese verwantskap tussen onafhanklike en afhanklike veranderlikes binne die studie is. ’n Kwantitatiewe beskrywende korrelerende navorsingsontwerp is toegepas en ’n gerieflikheidsmonster van n= 200 (8.5%) pasiënte is geselekteer uit ’n bevolking van N = 2349 by die Delftgemeenskap Gesondheidssentrum. ’n Veelkeusige vraelys wat hoofsaaklik uit geslote vrae met veelkeusige response bestaan het, is gebruik in individuele onderhoude wat deur of die navorser of veldwerker gevoer is. Betroubaarheid en geldigheid is verseker deur oorlegpleging met spesialiste op die gebied van navorsingsmetodologie, statistiek, HIV/VIGS en die Gesondheidsnavorsing se Etiese Komitee van die Universiteit van Stellenbosch. Toestemming om die navorsing te doen, is gegee deur die Gesondheidsnavorsing se Etiese Komitee van Stellenbosch Universiteit, die Provinsiale Streekshoof vir Primêre Gesondheidsdienste, asook die hoof van die Delftgemeenskap Gesondheidssentrum. Data het bewys dat die deelnemers hoofsaaklik vroulik is (n=145/72.5%) en die gemiddelde ouderdom 37.5 jaar. Deelnemers is meestal Xhosasprekend en geletterd en die meerderheid (n=112/56%) van die deelnemers se hoogste opleidingsvlak is tussen graad 9 en graad 12. Baie (n=73/36.5%) van die deelnemers het met HIV geleef vir 5 jaar, maar was op ART vir tussen 1 tot 3 jaar. Kennis is geassesseer deur vrae te stel oor verskeie aspekte van HIV en ART dwarsdeur die ondersoek. Puntetelling vir die 14 kritiese vrae het aan die lig gebring dat (n=0/0%) van die deelnemers goeie kennis het, (n=40/20%) van die deelnemers beskik oor gemiddelde kennis en (n=160/80%) van die deelnemers se kennis is gering. Die gemiddelde puntetelling vir al die deelnemers van al 20 kennisvrae wat getoets is, is (12.6/63%). Die bevindinge bewys dat die algehele kennis (n= 160/80%) gering is. Basiese terminologie en beginsels van HIV/VIGS en ART word nie begryp nie en ernstige wanopvattinge aangaande die siekte is geopenbaar.
Gerlach, Undine Ariane. "Interruption of antiretroviral treatment in HIV-infected children." Diss., lmu, 2004. http://nbn-resolving.de/urn:nbn:de:bvb:19-26945.
Full textCantrell, Ronald Alexander. "Diagnosing antiretroviral treatment failure in resource-limited settings." Thesis, Birmingham, Ala. : University of Alabama at Birmingham, 2008. https://www.mhsl.uab.edu/dt/2008p/cantrell.pdf.
Full textOgunsanwo, Damilola Akinkunle. "Determination of patient satisfaction at accredited antiretroviral treatment sites in the Gert Sibande District, Mpumalanga Province." Thesis, University of Limpopo (Medunsa Campus), 2012. http://hdl.handle.net/10386/778.
Full textCHAPTER 1 INTRODUCTION 1.1 INTRODUCTION This chapter presents the background and rationale for the study followed by the problem statement. The aim and objectives of the study as well as the significance of the study will also be explained. 1.2 BACKGROUND AND RATIONALE FOR THE STUDY In the past decade, patient satisfaction has become an important performance and outcome measure of health care (Moret, Nguyen, Pillet, Faissard, Lombrail & Gasquet, 2007). Although high levels of patient satisfaction are important for a successful strategy against Human Immuno-deficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), research into patient satisfaction with health care services in general, and with antiretroviral treatment (ART) services in particular, has been limited in South Africa (Myburgh, Solanki, Smith & Lalloo, 2005). In a weakened healthcare system, it is even more crucial to ensure a high quality of care and patient satisfaction to maximise the benefits of scarce resources. In addition, patient views on the quality of public sector antiretroviral (ARV) care are relatively unexplored (Igumbor, 2003; Myburgh et aI., 2005). The assessment of satisfaction among hospitalised patients is increasingly recognised as a major component of quality management in patient care. Continuous quality improvement, comparison of hospital performances and demands for accountability are some of the reasons that lead hospitals to measure patient satisfaction (Ross, Steward & Sinacore, 1995). As has been observed in many industrialised countries, the provision of ART via public health systems, can transform AIDS from a fast, insidious killer into a more manageable, though still incurable, chronic illness (Abdool Karim, 2005). However, in resource-limited settings, there are many challenges in successfully scaling-up ART and reorienting service delivery towards chronic disease care. Shortages in human resources for healthcare are often cited as the most important obstacle to a specific for all ART sites in the province should be developed and monitored. A long term strategy to address the critical shortage of healthcare professionals should be developed by provincial policy makers which will in the long run reduce long waiting times experienced by our clients.
Zhu, Hao. "Outcomes of China Free Antiretroviral Treatment Program, 2003--2010." THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, 2012. http://pqdtopen.proquest.com/#viewpdf?dispub=3495747.
Full textLarsson, Kiara. "Barriers to Access to Antiretroviral Treatment in Babati, Tanzania." Thesis, Södertörns högskola, Institutionen för naturvetenskap, miljö och teknik, 2016. http://urn.kb.se/resolve?urn=urn:nbn:se:sh:diva-30711.
Full textBooks on the topic "Antiretroviral Treatment"
Programmes, Namibia Ministry of Health and Social Services Directorate of Special. National guidelines for antiretroviral therapy. 3rd ed. Windhoek]: Ministry of Health and Social Services, Directorate of Special Programmes, 2010.
Find full textKane, Brigid M. HIV/AIDS treatment drugs. Edited by Triggle D. J. New York NY: Chelsea House, 2011.
Find full textSteinberg, Jonny. AIDS and AIDS treatment in a rural Southern African setting. Pretoria: Institute for Security Studies, 2008.
Find full textSteinberg, Jonny. AIDS and AIDS treatment in a rural Southern African setting. Pretoria: Institute for Security Studies, 2008.
Find full textInstitute for Security Studies (South Africa), ed. AIDS and AIDS treatment in a rural Southern African setting. Pretoria: Institute for Security Studies, 2008.
Find full textInstitute of Medicine (U.S.). Committee on Examining the Probable Consequences of Alternative Patterns of Widespread Antiretroviral Drug Use in Resource-Constrained Settings. Scaling up treatment for the global AIDS pandemic: Challenges and opportunities. Edited by Curran James W. Washington, DC: National Academies Press, 2005.
Find full textMalawi. Ministry of Health and Population. Treatment of AIDS: The 2 year plan to scale up antiretroviral therapy in Malawi, 2004-2005. Malawi]: Ministry of Health and Population, 2004.
Find full textServices, U. S. Department of Health and Human. Panel on clinical practices for the treatment of HIV infection: Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. [Baltimore, Md.?]: U.S. Dept of Health and Human Services, 2000.
Find full textForbes, Jack. Report on pediatric antiretroviral therapy: Survey of the ART treatment sites in Zimbabwe. Harare]: Ministry of Health and Child Welfare, National AIDS and TB Programe, 2007.
Find full textBook chapters on the topic "Antiretroviral Treatment"
Archary, Moherndran. "Antiretroviral Treatment." In HIV Infection in Children and Adolescents, 247–64. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-35433-6_19.
Full textHaire, Bridget. "Providing Universal Access While Avoiding Antiretroviral Resistance: Ethical Tensions in HIV Treatment." In Ethics and Drug Resistance: Collective Responsibility for Global Public Health, 37–54. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-27874-8_3.
Full textGuaraldi, Giovanni, André Fragoso Gomes, and Ana Rita Silva. "Antiretroviral Treatment in Older Patients." In Managing the Older Adult Patient with HIV, 129–80. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-20131-3_10.
Full textBrown, Kimberley C., Lisa D. Inge, and Mobeen H. Rathore. "Neurological Consequences of Antiretroviral Treatment." In The Neurological Manifestations of Pediatric Infectious Diseases and Immunodeficiency Syndromes, 173–84. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-391-2_11.
Full textWilliam Wester, C. "Antiretroviral Medications, Adult Care, and Treatment." In Encyclopedia of AIDS, 1–16. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4614-9610-6_166-1.
Full textMuiruri, Charles, Habib R. Omar, and John A. Bartlett. "Antiretroviral Treatment in Resource-Limited Settings." In Encyclopedia of AIDS, 1–11. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4614-9610-6_441-1.
Full textWilliam Wester, C. "Antiretroviral Medications, Adult Care, and Treatment." In Encyclopedia of AIDS, 72–87. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-7101-5_166.
Full textMuiruri, Charles, Habib R. Omar, and John A. Bartlett. "Antiretroviral Treatment in Resource-Limited Settings." In Encyclopedia of AIDS, 113–22. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-7101-5_441.
Full textWalters, Sam. "Practical Aspects of Antiretroviral Treatment in Children." In Advances in Experimental Medicine and Biology, 221–28. Boston, MA: Springer US, 2006. http://dx.doi.org/10.1007/0-387-33026-7_18.
Full textCapeau, J., M. Caron, and F. Boccara. "Pathogenesis of Antiretroviral Treatment-Associated Metabolic Syndrome." In Cardiovascular Disease in AIDS, 33–53. Milano: Springer Milan, 2009. http://dx.doi.org/10.1007/978-88-470-0761-1_3.
Full textConference papers on the topic "Antiretroviral Treatment"
Ciorbea, Iulia. "INCREASING ANTIRETROVIRAL TREATMENT ADHERENCE THROUGH PSYCHOTHERAPEUTIC STRATEGIES." In SGEM 2014 Scientific Conference on PSYCHOLOGY AND PSYCHIATRY, SOCIOLOGY AND HEALTHCARE, EDUCATION. Stef92 Technology, 2014. http://dx.doi.org/10.5593/sgemsocial2014/b11/s1.028.
Full textBariain, M. Ibar, M. Núñez de Sologuren, J. Montoya Matellanes, A. Larrabeiti Echevarría, V. Goitia Rubio, A. Martiarena Ayestaran, and AC Minguez Cabeza. "DI-029 Analysis of the modifications in antiretroviral treatment." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.276.
Full textPerpinya, M., J. Colomer, A. Gomez, and I. Vilaro. "CP-158 Use of antiretroviral dual therapy as an antiretroviral treatment switch strategy. experience in a community hospital." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.157.
Full textNotario Dongil, C., A. Perez Fácila, B. Proy Vega, MM Alañón Pardo, P. Araque Arroyo, and JC Valenzuela Gámez. "4CPS-064 Adherence to antiretroviral treatment in patients with HIV." In 25th EAHP Congress, 25th–27th March 2020, Gothenburg, Sweden. British Medical Journal Publishing Group, 2020. http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.165.
Full textHOSSAIN, FARIHA, and RAUSHANARA AKTER. "Treatment monitoring of antiretroviral drug on the basis of the adherence to the current antiretroviral therapy available in Bangladesh." In Eighth International Conference on Advances in Applied Science and Environmental Engineering - ASEE 2018. Institute of Research Engineers and Doctors, 2018. http://dx.doi.org/10.15224/978-1-63248-143-6-06.
Full textHabibah, Ummu, and Ririt Andria Sari. "The effectiveness of an antiretroviral treatment (ARV) and a highly active antiretroviral therapy (HAART) on HIV/AIDS epidemic model." In THE 8TH ANNUAL BASIC SCIENCE INTERNATIONAL CONFERENCE: Coverage of Basic Sciences toward the World’s Sustainability Challanges. Author(s), 2018. http://dx.doi.org/10.1063/1.5062794.
Full textRomero, J., A. Soria Martin, J. Garcia Marin, M. Fages, and JR Avila Alvarez. "4CPS-061 Adherence to antiretroviral treatment as a function of the complexity of the treatment." In 25th EAHP Congress, 25th–27th March 2020, Gothenburg, Sweden. British Medical Journal Publishing Group, 2020. http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.162.
Full textGILADA, ISHWAR, and T. GILADA. "PREVENTION OF HIV-1 INFECTION WITH EARLY ANTIRETROVIRAL THERAPY: TREATMENT AS PREVENTION—TASP." In International Seminar on Nuclear War and Planetary Emergencies — 46th Session. WORLD SCIENTIFIC, 2014. http://dx.doi.org/10.1142/9789814623445_0030.
Full textClerigo, Vera, Ana Castro, Teresa Mourato, and Conceição Gomes. "Impact of HIV status, CD4 count and antiretroviral treatment on tuberculosis treatment outcomes in a low-burden country." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa2723.
Full textBurnett, Trever M., Jonathon P. Parsons, Gary Phillips, Chris Waugh, Vladimir Bubelev, Karen Martin, Janice Drake, Philip T. Diaz, and John G. Mastronarde. "Does Treatment With Highly Active Antiretroviral Therapy (HAART) Cause Asthma In HIV-infected Adults?" In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a6648.
Full textReports on the topic "Antiretroviral Treatment"
Bärnighausen, Till, David Bloom, and Salal Humair. A Mathematical Model for Estimating the Number of Health Workers Required for Universal Antiretroviral Treatment. Cambridge, MA: National Bureau of Economic Research, November 2009. http://dx.doi.org/10.3386/w15517.
Full textDjimeu, Eric W., and Eleanor G. Dickens. Treatment as prevention: a replication study on early antiretroviral therapy initiation and HIV-1 transmission. International Initiative for Impact Evaluation (3ie), June 2020. http://dx.doi.org/10.23846/rps0024.
Full textBärnighausen, Till, and David Bloom. "Conditional scholarships" for HIV/AIDS Health Workers: Educating and Retaining the Workforce to Provide Antiretroviral Treatment in Sub-Saharan Africa. Cambridge, MA: National Bureau of Economic Research, September 2007. http://dx.doi.org/10.3386/w13396.
Full textShen, Chen, Jing Li, Ya-Jun Lian, Hui-Di Lan, Feng-Lan Pu, Wen-Jing Zhang, Ling-Yao Kong, and Jian-Ping Liu. Chinese Herbal Medicine in Incomplete Immune Reconstruction in AIDS Patients Experiencing Antiretroviral Treatment: A Systematic Review and Meta-Analysis of Randomized Trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2021. http://dx.doi.org/10.37766/inplasy2021.9.0073.
Full textDuggan, Mark, and William Evans. Estimating the Impact of Medical Innovation: A Case Study of HIV Antiretroviral Treatments. Cambridge, MA: National Bureau of Economic Research, February 2005. http://dx.doi.org/10.3386/w11109.
Full textAdherence to Antiretroviral Therapy in Adults: A Guide for Trainers. Population Council, 2004. http://dx.doi.org/10.31899/hiv15.1000.
Full textAntiretroviral treatment can reduce the risk of HIV transmission between male partners to ‘zero’. National Institute for Health Research, June 2019. http://dx.doi.org/10.3310/signal-000785.
Full textImpact of a community-based, HIV intervention on antiretroviral treatment retention and adherence in Tanzania. Population Council, 2016. http://dx.doi.org/10.31899/hiv7.1013.
Full textEarly results demonstrate the importance of early treatment of HIV and the feasibility and acceptability of community-based antiretroviral treatment delivery for female sex workers in Tanzania. Population Council, 2018. http://dx.doi.org/10.31899/hiv5.1008.
Full textReproductive intentions and choices among HIV-infected individuals in Cape Town, South Africa: Lessons for reproductive policy and service provision from a qualitative study. Population Council, 2005. http://dx.doi.org/10.31899/hiv14.1002.
Full text